Enhanced Antigiardial Effect of Omeprazole Analog Benzimidazole Compounds


Por: Hernandez-Ochoa, Beatriz, Gomez-Manzo, Saul, Sanchez-Carrillo, Adrian, Marcial-Quino, Jaime, Maria Rocha-Ramirez, Luz, Santos-Segura, Araceli, Jiovany Ramirez-Nava, Edson, Arreguin-Espinosa, Roberto, Cuevas-Cruz, Miguel, Mendez-Tenorio, Alfonso, Calderon-Jaimes, Ernesto

Publicada: 1 sep 2020
Resumen:
Giardiasis is a diarrheal disease that is highly prevalent in developing countries. Several drugs are available for the treatment of this parasitosis; however, failures in drug therapy are common, and have adverse effects and increased resistance of the parasite to the drug, generating the need to find new alternative treatments. In this study, we synthesized a series of 2-mercaptobenzimidazoles that are derivatives of omeprazole, and the chemical structures were confirmed through mass,H-1 NMR, and(13)C NMR techniques. The in vitro efficacy compounds againstGiardia, as well as its effect on the inhibition of triosephosphate isomerase (TPI) recombinant, were investigated, the inactivation assays were performed with 0.2 mg/mL of the enzyme incubating for 2 h at 37 degrees C in TE buffer, pH 7.4 with increasing concentrations of the compounds. Among the target compounds,H-BZM2,O2N-BZM7, andO(2)N-BZM9had greater antigiardial activity (IC50: 36, 14, and 17 mu M on trophozoites), and inhibited the TPI enzyme (K-2: 2.3, 3.2, and 2.8 M(-1)s(-1)) respectively, loading alterations on the secondary structure, global stability, and tertiary structure of the TPI protein. Finally, we demonstrated that it had low toxicity on Caco-2 and HT29 cells. This finding makes it an attractive potential starting point for new antigiardial drugs.

Filiaciones:
Hernandez-Ochoa, Beatriz:
 Hosp Infantil Mexico Dr Federico Gomez, Lab Inmunoquim, Secretaria Salud, Ciudad De Mexico 06720, Mexico

Gomez-Manzo, Saul:
 Inst Nacl Pediat, Lab Bioquim Genet, Secretaria Salud, Ciudad De Mexico 04530, Mexico

Sanchez-Carrillo, Adrian:
 Hosp Infantil Mexico Dr Federico Gomez, Lab Inmunoquim, Secretaria Salud, Ciudad De Mexico 06720, Mexico

Marcial-Quino, Jaime:
 Consejo Nacl Ciencia & Tecnol CONACYT, Secretaria Salud, Inst Nacl Pediat, Ciudad De Mexico 04530, Mexico

Maria Rocha-Ramirez, Luz:
 Hosp Infantil Mexico Dr Federico Gomez, Unidad Invest Enfermedades Infecciosas, Secretaria Salud Dr Marquez 162, Ciudad De Mexico 06720, Mexico

Santos-Segura, Araceli:
 Hosp Infantil Mexico Dr Federico Gomez, Lab Inmunoquim, Secretaria Salud, Ciudad De Mexico 06720, Mexico

Jiovany Ramirez-Nava, Edson:
 Inst Nacl Pediat, Lab Bioquim Genet, Secretaria Salud, Ciudad De Mexico 04530, Mexico

Arreguin-Espinosa, Roberto:
 Univ Nacl Autonoma Mexico, Inst Quim, Dept Quim Biomacromol, Ciudad De Mexico 04510, Mexico

Cuevas-Cruz, Miguel:
 Univ Nacl Autonoma Mexico, Inst Quim, Dept Quim Biomacromol, Ciudad De Mexico 04510, Mexico

Mendez-Tenorio, Alfonso:
 Inst Politecn Nacl, Lab Biotecnol & Bioinformat Genom, Escuela Nacl Ciencias Biol, Ciudad De Mexico 11340, Mexico

Calderon-Jaimes, Ernesto:
 Hosp Infantil Mexico Dr Federico Gomez, Lab Inmunoquim, Secretaria Salud, Ciudad De Mexico 06720, Mexico
ISSN: 14203049
Editorial
MDPI AG, POSTFACH, CH-4005 BASEL, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 25 Número: 17
Páginas:
WOS Id: 000570339900001
ID de PubMed: 32882836

MÉTRICAS